van der Wekken, A. J., Kok, K., & Groen, H. J. M. (2018). Is alectinib the new first line therapy in ALK-rearranged advanced non-small cell lung cancer? J Thorac Dis.
Chicago Stili Alıntıvan der Wekken, Anthonie J., Klaas Kok, ve Harry J. M. Groen. "Is Alectinib the New First Line Therapy in ALK-rearranged Advanced Non-small Cell Lung Cancer?" J Thorac Dis 2018.
MLA Alıntıvan der Wekken, Anthonie J., Klaas Kok, ve Harry J. M. Groen. "Is Alectinib the New First Line Therapy in ALK-rearranged Advanced Non-small Cell Lung Cancer?" J Thorac Dis 2018.
Uyarı: Bu alıntı herzaman %100 doğru olmayabilir..